Loading company…
Optolane develops digital diagnostic devices and software for point-of-care testing.
Optolane develops digital diagnostic kits and software for point-of-care testing of coronavirus, cancer and respiratory illnesses. Its semiconductor-integrated device combines optical and thermal control for real-time and digital PCR testing. Founded in 2012, the company is based in Seongnam, South Korea. In July 2023, it raised KRW 8.9 billion in pre-IPO funding from returning investors L&S Venture Capital and Solidus Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in